Algert Global’s Sana Biotechnology SANA Stock Holding History

Algert Global’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$588K	Sell	168,569 -52,300	-24%	-$168K	0.01%	1043
2026 Q1	$636K	Buy	220,869 +160,859	+268%	+$634K	0.01%	938
2025 Q4	$244K	Buy	+60,010	New	+$269K	﹤0.01%	1035
2024 Q3	–	Sell	-13,286	Closed	-$72.5K	–	1535
2024 Q2	$72.5K	Buy	+13,286	New	+$106K	﹤0.01%	1426
2024 Q1	–	Sell	-27,500	Closed	-$112K	–	1250
2023 Q4	$112K	Buy	+27,500	New	+$101K	﹤0.01%	1062

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Algert Global's SANA Position: Q2 2026 in Review

Algert Global reduced its Sana Biotechnology (SANA) stake by 24% in Q2 2026, selling an estimated $168K and leaving 168,569 shares worth $588K. The position accounts for 0.01% of the portfolio, ranked #1043.

Algert Global first reported a position in SANA in Q4 2023 and has held it in 5 quarters since. The position peaked at $636K in Q1 2026. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Algert Global held 168,569 shares of Sana Biotechnology worth $588K as of Q2 2026.
Algert Global sold 52,300 Sana Biotechnology shares in Q2 2026, an estimated $168K.
Sana Biotechnology made up 0.01% of Algert Global's portfolio in Q2 2026, its #1043 holding.
Algert Global first reported a position in Sana Biotechnology in Q4 2023 and has held it in 5 quarters since.
Algert Global's Sana Biotechnology position peaked at $636K in Q1 2026.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.